Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.

about

Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms Ginsenoside Rg3 Attenuates Lipopolysaccharide-Induced Acute Lung Injury via MerTK-Dependent Activation of the PI3K/AKT/mTOR Pathway

P2860

Q58592397-650B2EAB-EB14-48BF-BE48-6B0B3B8378BB Q58803436-4ED2F61C-4CB1-4538-B9D9-3473189213C0

P2860

Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.

Item

http://www.wikidata.org/entity/Q45375172

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ginsenoside Rg3 inhibits angio ...... 3K/Akt/mTOR signaling pathway.

@en

Ginsenoside Rg3 inhibits angio ...... 3K/Akt/mTOR signaling pathway.

@nl

type

Item

label

Ginsenoside Rg3 inhibits angio ...... 3K/Akt/mTOR signaling pathway.

@en

Ginsenoside Rg3 inhibits angio ...... 3K/Akt/mTOR signaling pathway.

@nl

prefLabel

Ginsenoside Rg3 inhibits angio ...... 3K/Akt/mTOR signaling pathway.

@en

Ginsenoside Rg3 inhibits angio ...... 3K/Akt/mTOR signaling pathway.

@nl

P1476

Ginsenoside Rg3 inhibits angio ...... I3K/Akt/mTOR signaling pathway

@en

P2093

Jieyun Zhou

http://www.w3.org/2001/XMLSchema#string

Jingang Cui

http://www.w3.org/2001/XMLSchema#string

Lin Cao

http://www.w3.org/2001/XMLSchema#string

Mengfei Zhuang

http://www.w3.org/2001/XMLSchema#string

Qing Ye

http://www.w3.org/2001/XMLSchema#string

Ruihua Zhong

http://www.w3.org/2001/XMLSchema#string

Shuwu Xie

http://www.w3.org/2001/XMLSchema#string

Yan Zhu

http://www.w3.org/2001/XMLSchema#string

Yang Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Marine compound catunaregin inhibits angiogenesis through the modulation of phosphorylation of akt and eNOS in vivo and in vitro.

Antiangiogenesis therapy of endometriosis using PAMAM as a gene vector in a noninvasive animal model.

Anti-angiogenic treatment strategies for the therapy of endometriosis.

Recurrence of endometriosis and its control.

Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.

The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice.

Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis.

Increased expression of pattern recognition receptors and nitric oxide synthase in patients with endometriosis.

NME1 suppression of endometrial stromal cells promotes angiogenesis in the endometriotic milieu via stimulating the secretion of IL-8 and VEGF.

Angiogenesis as a therapeutic target in endometriosis.

P304

e0186520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0186520

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tingting Zhang

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29140979

http://www.w3.org/2001/XMLSchema#string

P921

endometriosis

P932

5687597

http://www.w3.org/2001/XMLSchema#string

Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.

about

P2860

P2860

Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932